These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24591390)

  • 1. Opana ER abuse and thrombotic thrombocytopenic purpura (TTP)-like illness: a rising risk factor in illicit drug users.
    Kapila A; Chhabra L; Chaubey VK; Summers J
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24591390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(1):1-4. PubMed ID: 23302815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH OPANA ER INTRAVENOUS ABUSE A Case Report.
    Jabr FI; Yu L
    J Med Liban; 2016; 64(1):40-2. PubMed ID: 27169165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange.
    Miller PJ; Farland AM; Knovich MA; Batt KM; Owen J
    Am J Hematol; 2014 Jul; 89(7):695-7. PubMed ID: 24668845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy and acute kidney injury associated with intravenous abuse of an oral extended-release formulation of oxymorphone hydrochloride: kidney biopsy findings and report of 3 cases.
    Ambruzs JM; Serrell PB; Rahim N; Larsen CP
    Am J Kidney Dis; 2014 Jun; 63(6):1022-6. PubMed ID: 24529995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resurgence of intravenous Opana as a cause of secondary thrombotic thrombocytopenic purpura.
    Rane M; Aggarwal A; Banas E; Sharma A
    Am J Emerg Med; 2014 Aug; 32(8):951.e3-4. PubMed ID: 24630802
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic microangiopathy associated with intravenous injection of extended-release oxycodone.
    Robson KJ; Clucas D; Filshie R; Nandurkar H
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opana-ER used the wrong way: intravenous abuse leading to microangiopathic hemolysis and a TTP-like syndrome.
    Amjad AI; Parikh RA
    Blood; 2013 Nov; 122(20):3403. PubMed ID: 24369032
    [No Abstract]   [Full Text] [Related]  

  • 9. Bilateral exudative retinal detachments due to thrombotic microangiopathy associated with intravenous abuse of Opana ER.
    Aseem F; Zamora BG; Kauffman L; Miller PJ; John VJ
    Am J Ophthalmol Case Rep; 2018 Sep; 11():72-74. PubMed ID: 29998206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging.
    Bonnecaze AK; Wilson MW; Dharod A; Fletcher A; Miller PJ
    Nephrology (Carlton); 2018 Oct; 23(10):921-926. PubMed ID: 28802086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.
    Hunt R; Yalamanoglu A; Tumlin J; Schiller T; Baek JH; Wu A; Fogo AB; Yang H; Wong E; Miller P; Buehler PW; Kimchi-Sarfaty C
    Blood; 2017 Feb; 129(7):896-905. PubMed ID: 27864296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone.
    Wilson MW; Bonnecaze AK; Dharod A; Miller PJ
    South Med J; 2017 Mar; 110(3):217-222. PubMed ID: 28257549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER.
    Thakur K; Agrawal V; Kass A; Dimarino LM; Dorion RP; Vadakara J
    Case Rep Hematol; 2017; 2017():1623907. PubMed ID: 28607779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opana ER-induced thrombotic microangiopathy.
    Lämmle B
    Blood; 2017 Feb; 129(7):808-809. PubMed ID: 28209752
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome.
    Gandhi A; Ullah S; Kotadia S; Nasser S
    J Ayub Med Coll Abbottabad; 2017; 29(2):360-362. PubMed ID: 28718268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura.
    Ban BH; Verma A; Tudor M; Sethi J
    Oxf Med Case Reports; 2017 Jun; 2017(6):omx026. PubMed ID: 28580158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opana ER (Oxymorphone)-Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C.
    Mehmood H; Khan M; Marwat A; Joshi M; Malhotra V
    J Investig Med High Impact Case Rep; 2018; 6():2324709618756423. PubMed ID: 29435466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid associated intravenous and cutaneous microvascular drug abuse (skin-popping) masquerading as Degos disease (malignant atrophic papulosis) with multiorgan involvement.
    Magro CM; Toledo-Garcia A; Pala O; Momtahen S; Shapiro L
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opana(®) ER induced thrombotic thrombocytopenic purpura.
    Kotbi N; Han B; Cheng D; Odom AE
    Int Med Case Rep J; 2015; 8():97-8. PubMed ID: 25995651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case off TTP temporally associated with cocaine use: Implications for treatment of suspected DITMA.
    Regner SR; Lerfald N
    J Clin Apher; 2019 Aug; 34(4):510-512. PubMed ID: 30776151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.